Related Experiment Video
Updated: Aug 11, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Review of randomised trials using the post-randomised consent (Zelen's) design
Joy Adamson1, Sarah Cockayne, Suezann Puffer
1York Trials Unit, Department of Health Sciences, University of York, York YO10 5DD, UK.
Zelen's method randomizes participants before consent to reduce bias, a common reason for its use. Despite ethical concerns, recent trials show manageable crossover rates, suggesting its careful application can be effective.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Medical Ethics
Background:
- Zelen described a pre-consent randomization method in 1979 to improve clinical trial recruitment.
- This method faces ethical criticism regarding consent and scientific critique over high crossover rates.
- This review examines recent trials employing Zelen's method, their justifications, crossover rates, and overall quality.
Purpose of the Study:
- To review recent trials utilizing Zelen's method.
- To identify authors' stated reasons for employing this randomization technique.
- To assess crossover rates and the quality of trials using Zelen's method.
Main Methods:
- A literature review was conducted, searching for trials citing Zelen's papers since 1990.
- Personal knowledge was used to include additional relevant trials.
- The review focused on identifying justifications, crossover data, and trial quality.
Main Results:
- 58 relevant trials were identified.
- The primary justification for using Zelen's method was to prevent bias, such as the Hawthorne effect.
- While 41 trials reported crossover (median 8.9%), it was generally within acceptable limits; few trials explicitly aimed to enhance recruitment.
Conclusions:
- Limiting bias, including the Hawthorne effect and 'resentful demoralization', was the main reason authors cited for using Zelen's method.
- Careful implementation of Zelen's method can mitigate bias in clinical trials.
- Contrary to previous reviews, this study found crossover rates to be manageable in most trials.
Related Concept Videos
Randomized Experiments
Simple randomization
Simple...
Blinding
Blind Procedures
Experimental Designs
Group Design
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
